Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BAR12: Bayesian Autoregressive Phase 1-2 Design for Cell Therapy Trials With Manufacturing Changes.

Statistics in medicine·2026
Same author

High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Precision generalized phase I-II designs.

Biometrics·2025
Same author

Practical Bayesian Guidelines for Small Randomized Oncology Trials.

Cancers·2025
Same author

Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility-Based Rule.

Statistics in medicine·2024
Same journal

Bayesian Transfer Learning.

Statistical science : a review journal of the Institute of Mathematical Statistics·2026
Same journal

On the mixed-model analysis of covariance in cluster-randomized trials.

Statistical science : a review journal of the Institute of Mathematical Statistics·2026
Same journal

Replicable Bandits for Digital Health Interventions.

Statistical science : a review journal of the Institute of Mathematical Statistics·2026
Same journal

Statistical Inference for the Evolutionary History of Cancer Genomes.

Statistical science : a review journal of the Institute of Mathematical Statistics·2025
Same journal

Causal Inference Methods for Combining Randomized Trials and Observational Studies: A Review.

Statistical science : a review journal of the Institute of Mathematical Statistics·2025
Same journal

On the Use of Auxiliary Variables in Multilevel Regression and Poststratification.

Statistical science : a review journal of the Institute of Mathematical Statistics·2025
See all related articles

Related Experiment Videos

Bayesian Models and Decision Algorithms for Complex Early Phase Clinical Trials.

Peter F Thall1

  • 1Department of Biostatistics, University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA.

Statistical Science : a Review Journal of the Institute of Mathematical Statistics
|February 15, 2011
PubMed
Summary
This summary is machine-generated.

Early phase clinical trials evaluate new treatments, aiming to find safe doses. Model-based adaptive designs show success despite implementation challenges in clinical practice.

Related Experiment Videos

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Drug Development

Background:

  • Early phase clinical trials are crucial for assessing new anti-disease agents in humans.
  • Traditionally focused on dose-finding based on adverse events, often in cancer treatment.
  • Modern designs increasingly use model-based, outcome-adaptive rules for dose selection.

Purpose of the Study:

  • To review Bayesian early phase clinical trial designs.
  • To address complexities in treatment regimens and patient outcomes.
  • To highlight successful applications of adaptive designs.

Main Methods:

  • Review of Bayesian statistical designs for early phase trials.
  • Focus on designs accommodating specific clinical complexities.
  • Discussion of outcome-adaptive decision rules.

Main Results:

  • Model-based outcome-adaptive designs have shown remarkable success.
  • These designs benefit both patients and scientific outcomes.
  • Despite complexity, successful applications exist in various medical settings.

Conclusions:

  • Bayesian adaptive designs offer a powerful approach for early phase trials.
  • Tailored designs can overcome challenges in complex clinical settings.
  • Further adoption of these successful methods is warranted.